Reports on Disease Progression Findings from U.S. Food and Drug Administration (FDA) Provide New Insights (Fdaapproval Summary: Olaparib Monotherapy or In Combination With Bevacizumab for the Maintenance Treatment of Patients With Advanced ...)

Source :: Women's Health Weekly. November 19, 2020, 1865
Publication Year :: 2020
Abstract: 2020 NOV 19 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on Disease Attributes - Disease Progression. According to news reporting [...]

Subjects :: United States. Food and Drug Administration -- Reports
Olaparib -- Research
Bevacizumab -- Research
Women's health -- Research -- Reports
Medical research -- Reports
Ovarian cancer -- Research -- Drug therapy
Health
Women's issues/gender studies

Tools